SCHEMBL13264078

SCHEMBL13264078

O=C(C(=O)c1ccc(F)c(CCO)c1)c1ccc(OC(F)F)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX15 P16050 1/20 0.43
▸ GFER P55789 1/20 0.43
▸ ADAM17 P78536 1/20 0.43
▸ ATM Q13315 1/20 0.42
▸ CES2 O00748 1/20 0.40
▸ CES1 P23141 1/20 0.40
▸ ALDH1A1 P00352 4/20 0.39
▸ HTT P42858 2/20 0.39
▸ MRGPRX4 Q96LA9 1/20 0.38
▸ PPARG P37231 1/20 0.38
▸ PPARA Q07869 1/20 0.38
▸ EPHX2 P34913 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ MDM2 Q00987 1/20 0.37
▸ HDAC3 O15379 1/20 0.37
▸ HDAC4 P56524 1/20 0.37
▸ HDAC1 Q13547 1/20 0.37
▸ HDAC7 Q8WUI4 1/20 0.37
▸ HDAC2 Q92769 1/20 0.37
▸ HDAC10 Q969S8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8187249 0.89 ALOX15 (0.43) ALOX15GFERADAM17ATMCES2
SCHEMBL2793181 0.86 ALOX15 (0.45) ALOX15GFERADAM17ATMCES2
SCHEMBL2796169 0.84 HTT (0.39) ALOX15GFERADAM17ATMCES2
SCHEMBL18097542 0.78 ALOX15 (0.39) ALOX15GFERADAM17ATMALDH1A1
SCHEMBL2791543 0.77 ALOX15 (0.51) ALOX15GFERADAM17ATMCES2
SCHEMBL2794479 0.77 ALOX15 (0.47) ALOX15GFERADAM17ATMCES2
SCHEMBL2791684 0.77 ALOX15 (0.66) ALOX15GFERADAM17ATMCES2
SCHEMBL2794505 0.76 BACE1 (0.41) ALOX15GFERADAM17ATMCES2
SCHEMBL4308568 0.76 PDE4A (0.49) CES2CES1HTTSMN1; SMN2LMNA
SCHEMBL15955676 0.73 CES2 (0.55) ALOX15GFERADAM17ATMCES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100168194-A1 Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone Compounds For The Inhibition Of Beta-secretase WYETH LLC (US) 2010-07-01 — — US disclosed
US-7723368-B2 Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone compounds for the inhibition of beta-secretase WYETH LLC (US) 2010-05-25 — — US disclosed
US-20090048320-A1 AMINO-5-[4-(DIFLUOROMETHOXY)PHENYL]-5-PHENYLIMIDAZOLONE COMPOUNDS FOR THE INHIBITION OF BETA-SECRETASE WYETH (US) 2009-02-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090048320-A1 AMINO-5-[4-(DIFLUOROMETHOXY)PHENYL]-5-PHENYLIMIDAZOLONE COMPOUNDS FOR THE INHIBITION OF BETA-SECRETASE BACE1, BACE2, APP ALOX15 3444/4885GFER 3887/4885ADAM17 16/4885
US-20100168194-A1 Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone Compounds For The Inhibition Of Beta-secretase BACE1, BACE2, APP ALOX15 3444/4885GFER 3887/4885ADAM17 16/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback